Driving research, providing support and improving outcomes for patients and their families affected by rare conditions



Currently Funded Research

The Myrovlytis Trust  has funded over £6 million of BHD research. See the research projects we are currently funding below.
Current BHD Research Projects Funded by the Myrovlytis Trust

Dr Neil Rajan,
Newcastle University, UK       

Delineating the Cutaneous Tumour Microenvironment in Birt-Hogg-Dubé Syndrome                                                                                    

Learn more about Neil’s research project here.

Dr Arjan Houweling,
Amsterdam UMC, The Netherlands

Improving Care for Birt-Hogg-Dubé Syndrome Patients: Clinical and Genetic Analysis of a Unique Cohort                                    

Learn more about Arjan’s research project here.

Professor Stefan Marciniak,
University of Cambridge, UK

Determining the Prevalence of Pathogenic FLCN Variants from Large Genomic Registries                          


Learn more about Stefan’s research project here.

Professor Mark Lowdell,
UCL, UK                                                              

Assessment of Human NK Cell Responses and Potentiation in Patients with Renal Cell Cancer – Pre-clinical Study to Support a Phase 2a Clinical Trial 

Learn more about Mark’s research project here.

Professor Masaya Baba,
Kumamoto University, Japan

CRISPR/Cas9 Mediated Unbiased Genome Wide Screening to Target both Tumour Cell Autonomous and Tumour Microenvironmental Factors in FLCN Deficient RCC Cells

Learn more about Masaya’s research project here.

Dr Fulya Taylan,
Karolinska Institute, Sweden

Investigating Molecular Mechanisms of an Autosomal Recessive FLCN-related Disorder Resembling Biallelic FNIP1 Disorder

Learn more about Fulya’s research project here.

University of Cambridge, Mass General Brigham, Asher Orion Group and Rhino Health

Developing AI solutions via Federated Learning to aid the diagnosis of Birt-Hogg-Dubé syndrome and other rare genetic causes of pneumothorax

Learn more about this research project here.

Current Osteosarcoma Research Projects Funded by the Myrovlytis Trust

Dr Wolfgang Paster,
Children’s Cancer Research Institute, Vienna, Austria

The Immunopeptidome of Paediatric High-Grade Osteosarcoma                                                                                                                    

Learn more about Wolfgang’s research project here.

Professor Nancy DeMore,
Medical University of South Carolina, USA

Combination Therapy with a Humanized Monoclonal Antibody to Secreted Frizzled Related Protein 2 for Metastatic Osteosarcoma

Learn more about Nancy’s research project here.

Professor Graham Cook and Dr Fiona Errington-Mais,
University of Leeds, UK

Oncolytic Virus-based Activation of Natural Killer Cells for the Immunotherapy of Osteosarcoma                                                     

Learn more about Graham and Fiona’s research project here.

Partnerships

Memberships

Osteosarcoma Institute
Bardo Foundation
Rare Revolution Magazine
Gene People logo
Gene People logo
Sarcoma Patient advocacy Global Network
Connect with us…
Back to top